Stilbenoid Scaffolds at the Interface of Anxiety and Glucose Homeostasis: A Mechanistic and Translational Review of Preclinical Evidence and Evaluation Strategies

Anxiety and type 2 diabetes mellitus (T2DM) are frequently associated conditions that share several pathophysiological mechanisms, including oxidative stress, neuroinflammation, insulin resistance, and dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis. The bidirectional relationship between metabolic dysfunction and anxiety highlights the need to investigate pharmacological agents that may influence both neurological and metabolic parameters. Lunularin, a dihydrostilbene and gut microbial metabolite of resveratrol, has attracted interest because of its potential biological activities. However, its anxiolytic potential and influence on glucose homeostasis remain insufficiently investigated. The present study aims to investigate the anxiolytic potential of lunularin and its influence on glucose homeostasis in an experimental model of type 2 diabetes mellitus. Diabetes will be induced in Wistar rats using streptozotocin and nicotinamide (STZ–NA). Animals will be divided into appropriate experimental groups, including normal control, diabetic control, standard treatment, and lunularin-treated groups at selected dose levels. The anxiolytic potential of lunularin will be evaluated using behavioural paradigms such as the elevated plus maze and actophotometer, while locomotor activity and motor coordination will be assessed to distinguish anxiolytic effects from nonspecific behavioural changes. Glucose homeostasis will be evaluated through fasting blood glucose, glycated haemoglobin, and relevant metabolic parameters. Biochemical investigations may include oxidative stress markers, antioxidant status, and selected molecular pathways associated with metabolic and behavioural regulation. Histopathological examination of relevant tissues will provide additional evidence of treatment-associated changes.The study is expected to provide preliminary experimental evidence regarding the relationship between lunularin-mediated behavioural responses and glucose regulation in diabetic animals. The findings may contribute to understanding the pharmacological potential of lunularin and identify directions for further mechanistic and translational research.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24413545
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Stilbenoid Scaffolds at the Interface of Anxiety and Glucose Homeostasis: A Mechanistic and Translational Review of Preclinical Evidence and Evaluation Strategies

Mahadev Anitha, Hajera Begum, Dr. Koppala R. V. S. Chaitanya, Bommu Vaishnavi
Zenodo (CERN European Organization for Nuclear Research)
Natural Antidiabetic Agents Studies
article

Stilbenoid Scaffolds at the Interface of Anxiety and Glucose Homeostasis: A Mechanistic and Translational Review of Preclinical Evidence and Evaluation Strategies

Mahadev Anitha, Hajera Begum, Dr. Koppala R. V. S. Chaitanya, Bommu Vaishnavi
article en

Abstract

Anxiety and type 2 diabetes mellitus (T2DM) are frequently associated conditions that share several pathophysiological mechanisms, including oxidative stress, neuroinflammation, insulin resistance, and dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis. The bidirectional relationship between metabolic dysfunction and anxiety highlights the need to investigate pharmacological agents that may influence both neurological and metabolic parameters. Lunularin, a dihydrostilbene and gut microbial metabolite of resveratrol, has attracted interest because of its potential biological activities. However, its anxiolytic potential and influence on glucose homeostasis remain insufficiently investigated. The present study aims to investigate the anxiolytic potential of lunularin and its influence on glucose homeostasis in an experimental model of type 2 diabetes mellitus. Diabetes will be induced in Wistar rats using streptozotocin and nicotinamide (STZ–NA). Animals will be divided into appropriate experimental groups, including normal control, diabetic control, standard treatment, and lunularin-treated groups at selected dose levels. The anxiolytic potential of lunularin will be evaluated using behavioural paradigms such as the elevated plus maze and actophotometer, while locomotor activity and motor coordination will be assessed to distinguish anxiolytic effects from nonspecific behavioural changes. Glucose homeostasis will be evaluated through fasting blood glucose, glycated haemoglobin, and relevant metabolic parameters. Biochemical investigations may include oxidative stress markers, antioxidant status, and selected molecular pathways associated with metabolic and behavioural regulation. Histopathological examination of relevant tissues will provide additional evidence of treatment-associated changes.The study is expected to provide preliminary experimental evidence regarding the relationship between lunularin-mediated behavioural responses and glucose regulation in diabetic animals. The findings may contribute to understanding the pharmacological potential of lunularin and identify directions for further mechanistic and translational research.

Zenodo (CERN European Organization for Nuclear Research)
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon